Found 5 matching trials
Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020 PHASE2 A Six-Week, Randomized, Double-Blind, Parallel Group Extension Study To Eva...
Show More Location
University of California, Irvine
Learn More & Join Trial
Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder PHASE2 An open-label, multi-center, 6-week, sequential cohort study designed to de...
Show More Location
Dept. of Psychiatry, Sheba Medical Center
Learn More & Join Trial
Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia PHASE2 This is a randomized, double-blind, active-controlled, 6 month study design...
Show More Location
Department of Psychiatry, Sheath VS General Hospital, Sheath KM School of Post Graduate Medicine & Research
Learn More & Join Trial
A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer PHASE1 This is a single dose, open-label, 2-panel (Parts A and B) PET study invest...
Show More Location
Quintiles Phase I facility
Learn More & Join Trial
A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study PHASE2 This is a prospective, six-week, randomized, double blind, placebo-controll...
Show More Location
Mary ann Knisevich
Learn More & Join Trial